ArticleJournal of hematology & oncology2025

A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma.

Huangming Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.